Protai
Dr. Shacham is a serial entrepreneur in the fields of Biotech and climate. Dr. Shacham is currently a co-founder and general partner at E44 Ventures, a new studio venture focused on partnering with academia and early ideators, to build technology-based companies to contribute to a cleaner, more sustainable future for the planet. Prior to that, Dr. Shacham founded Karyopharm Therapeutics (NASDAQ: KPTI) where she created the novel oral cancer drug Xpovio® , and led its development from idea to commercialization: Xpovio is now approved worldwide.
This person is not in the org chart
This person is not in any offices
Protai
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.